As of 2024-12-15, the EV/EBITDA ratio of SHL Telemedicine Ltd (SHLTN.SW) is -80.47. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SHLTN.SW's latest enterprise value is 46.91 mil CHF. SHLTN.SW's TTM EBITDA according to its financial statements is -0.58 mil CHF. Dividing these 2 quantities gives us the above SHLTN.SW EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 11.2x | 9.8x |
| Forward P/E multiples | 10.9x - 13.6x | 12.6x |
| Fair Price | (0.73) - (0.74) | (0.74) |
| Upside | -129.4% - -129.8% | -129.8% |
| Date | EV/EBITDA |
| 2024-12-13 | -81.76 |
| 2024-12-12 | -80.36 |
| 2024-12-11 | -80.64 |
| 2024-12-10 | -76.98 |
| 2024-12-09 | -83.17 |
| 2024-12-06 | -79.51 |
| 2024-12-05 | -79.51 |
| 2024-12-04 | -77.83 |
| 2024-12-03 | -77.83 |
| 2024-12-02 | -80.92 |
| 2024-11-29 | -81.76 |
| 2024-11-28 | -79.80 |
| 2024-11-27 | -82.04 |
| 2024-11-26 | -79.51 |
| 2024-11-25 | -82.04 |
| 2024-11-22 | -81.48 |
| 2024-11-20 | -81.76 |
| 2024-11-19 | -81.48 |
| 2024-11-18 | -81.76 |
| 2024-11-15 | -82.33 |
| 2024-11-14 | -79.51 |
| 2024-11-13 | -79.80 |
| 2024-11-12 | -82.33 |
| 2024-11-11 | -82.33 |
| 2024-11-08 | -82.33 |
| 2024-11-07 | -82.33 |
| 2024-11-06 | -79.51 |
| 2024-11-05 | -79.51 |
| 2024-11-04 | -76.98 |
| 2024-11-01 | -76.98 |
| 2024-10-31 | -82.33 |
| 2024-10-30 | -82.33 |
| 2024-10-29 | -76.42 |
| 2024-10-25 | -82.33 |
| 2024-10-24 | -82.04 |
| 2024-10-23 | -82.33 |
| 2024-10-22 | -82.33 |
| 2024-10-21 | -81.76 |
| 2024-10-18 | -81.48 |
| 2024-10-17 | -81.76 |
| 2024-10-16 | -81.76 |
| 2024-10-15 | -79.51 |
| 2024-10-14 | -81.48 |
| 2024-10-11 | -81.48 |
| 2024-10-10 | -81.48 |
| 2024-10-09 | -76.70 |
| 2024-10-08 | -81.76 |
| 2024-10-07 | -82.33 |
| 2024-10-04 | -91.32 |
| 2024-10-03 | -87.67 |